Nevertheless, they differ significantly in their origin and structure, along with some significant changes in administration and the types of body tissues that most affect them.
So let us first define each product.
TB-500 is a synthetically produced thymosin beta 4, a protein produced by the thymus. It exerts healing properties through several mechanisms, including upregulation of actin, improved blood vessel formation (angiogenesis), and reduction of inflammation.
BPC-157 is a synthetic peptide similar to the body protection compound, a natural peptide found in the gastrointestinal tract that aids in digestion and ulcer healing.
Although BPC-157 is based on a naturally occurring body protection compound, its sequence does not exist in nature, so it is truly a synthetic peptide. This is in contrast to TB-500, which reflects the structure of natural thymosin beta 4.
In terms of improving healing and recovery, TB-500 and BPC-157 share several mechanisms of action. For example, BPC 157 also improves cell survival and migration, and angiogenesis. These are all core features of the TB500.
Clinical studies have observed that both peptides powerfully heal damaged joints, muscle, bone, and connective tissue.
Understandably, both products are effective. But when talking in terms of promoting recovery in a specific animal, will one be better than the other?
TB-500 Vs. BPC-157
One main difference between the two compounds is their route of administration (that is, the way the product is given to the animals).
Dosage for TB-500 and BPC-157
TB-500 is usually given once or twice a week, in a total dose of 10 to 20 mg per week.
On the other hand, BPC157 is given daily at 250 mcg (0.25 mg) to 1000 mcg (1 mg). This means that the weekly dose is 1.75 mg to 7 mg, significantly less than the corresponding one.
Perhaps more importantly, TB-500 has a systemic effect, meaning it promotes healing in injured tissue throughout the animal’s body regardless of administration location.
However, BPC-157 has a local healing effect. This means that damaged tissue will benefit most near the application site.
In addition, studies have shown that BPC157 has powerful healing and protective effects on the gastrointestinal system and nervous tissue. As a result, there is evidence that oral administration, even considering local healing effects, effectively promotes recovery and protection from injury in these areas.
Other Possible Differences
Anecdotally, some veterinarians report that TB500 is more beneficial than BPC157 in animal muscle tissue. This is especially related to its growth and strength-promoting effects. On the other hand, many reports indicate that both peptides have similar (strong) healing and protective effects on joint, bone, and connective tissue.
As a result, some animal trainers choose TB-500 as a more powerful and growth-promoting aid than BPC-157 if the only goal is the development of lean body mass in the animal. At the same time, other veterinarians have reported slightly better
healing results from BPC157 injuries.
An increase in healing effect must be often observed in animals, as when the two peptides are administered simultaneously, both can restore healing via complementary mechanisms.
Therefore, combining both peptides can provide an effective synergistic effect that provides maximum growth and healing benefits.
NOTE: The information found on this website and within this article is intended for educational or informational purposes only. Some or all of the content in these articles are not substantiated by a medical professional and may be based on the opinions of the writer, who may not be a medical or accredited professional. Not intended for personal use. Please review our Terms and Conditions.